Benzinga's Top Upgrades, Downgrades For November 14, 2017

Analysts at Deutsche Bank upgraded Zimmer Biomet Holdings Inc ZBH from Hold to Buy. Zimmer Biomet shares rose 0.28 percent to close at $111.06 on Monday.
Wells Fargo upgraded The Coca-Cola Co KO from Market Perform to Outperform. Coca-Cola shares rose 0.49 percent to $46.95 in pre-market trading.
Craig-Hallum upgraded Famous Dave's of America, Inc. DAVE from Hold to Buy. Famous Dave's of America shares rose 7.69 percent to $4.20 in pre-market trading.
Raymond James upgraded ADMA Biologics Inc ADMA from Market Perform to Outperform. ADMA Biologics shares climbed 8.87 percent to $2.70 in pre-market trading.
HSBC upgraded Deutsche Bank AG (USA) DB from Hold to Buy. Deutsche Bank shares rose 0.67 percent to $18.05 in pre-market trading.
Citigroup upgraded Marcus & Millichap Inc MMI from Neutral to Buy. Marcus & Millichap shares declined 0.70 percent to close at $29.87 on Friday.
Barclays upgraded CVR Refining LP CVRR from Underweight to Equal-Weight. CVR Refining shares gained 2.53 percent to $12.15 in pre-market trading.
Analysts at KeyBanc upgraded Knight-Swift Transportation Holdings Inc KNX from Sector Weight to Overweight. Knight-Swift shares fell 0.89 percent to close at $38.04 on Friday.
Analysts at Pivotal Research upgraded Time Warner Inc TWX from Hold to Buy. Time Warner shares rose 0.35 percent to $88.80 in pre-market trading.

RBC Capital downgraded General Electric Company GE from Outperform to Sector Perform. General Electric shares fell 0.16 percent to $18.99 in pre-market trading.
Barclays downgraded Phillips 66 PSX from Equal-Weight to Underweight. Phillips 66 shares declined 0.88 percent to $92.50 in pre-market trading.
Buckingham downgraded PulteGroup, Inc. PHM from Buy to Neutral. PulteGroup shares fell 2 percent to $30.95 in pre-market trading.
Morgan Stanley downgraded RPC, Inc. RES from Equal-Weight to Underweight. RPC shares declined 2.46 percent to close at $24.15 on Friday.
Deutsche Bank downgraded Teleflex Incorporated TFX from Buy to Hold. Teleflex shares dropped 1.32 percent to $253.55 in pre-market trading.
Analysts at Morgan Stanley downgraded JD.Com Inc(ADR) JD from Overweight to Equal-Weight. JD.com shares declined 1.67 percent to $40.65 in pre-market trading.
Analysts at Baird downgraded Beigene Ltd (ADR) BGNE from Outperform to Neutral. BeiGene shares dropped 0.31 percent to $82.92 in pre-market trading.
Berenberg downgraded Royal Caribbean Cruises Ltd RCL from Buy to Hold. Royal Caribbean shares declined 0.47 percent to $123.89 in pre-market trading.
BMO Capital downgraded Statoil ASA(ADR) STO from Outperform to Market Perform. Statoil shares slipped 1.16 percent to $20.45 in pre-market trading.
Raymond James downgraded Asanko Gold Inc AKG from Outperform to Market Perform. Asanko Gold shares fell 2.04 percent to close at $0.960 on Friday.

Morgan Stanley initiated coverage on RISE Education Cayman Ltd (ADR) REDU with an Overweight rating. RISE Education Cayman shares closed at $10.81 on Monday.
Cowen & Co. initiated coverage on Sea Ltd (ADR) SE with an Outperform rating. The price target for Sea Ltd set to $18. Sea Ltd shares closed at $14.73 on Monday.
Analysts at H.C. Wainwright assumed coverage on TG Therapeutics Inc TGTX with a Buy rating. The price target for TG Therapeutics set to $33. TG Therapeutics shares closed at $8.25 on Monday.
Analysts at Goldman Sachs assumed coverage on Dollar General Corp. DG with a Neutral rating. The price target for Dollar General is set to $89. Dollar General shares closed at $83.55 on Monday.
Baird initiated coverage on Hamilton Beach Brands Holding Co HBB with a Neutral rating. The price target for Hamilton Beach Brands is set to $29. Hamilton Beach Brands shares closed at $31.88 on Monday.
Analysts at Stifel Nicolaus initiated coverage on Sea Ltd (ADR) SE with a Buy rating. The price target for Sea Ltd is set to $19. Sea Ltd shares closed at $14.73 on Monday.
Goldman Sachs assumed coverage on Kroger Co KR with a Neutral rating. The price target for Kroger is set to $22. Kroger shares closed at $22.14 on Monday.
Analysts at B. Riley initiated coverage on Sucampo Pharmaceuticals, Inc. SCMP with a Buy rating. The price target for Sucampo Pharmaceuticals is set to $14. Sucampo Pharmaceuticals shares closed at $10.30 on Monday.

Analyst Calendar